May 2018 Issue of MMM
Intriguing data on the economics and impact of co-pay coupons and programs
Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.
Read the May 2018 issue in its entirety.
Pharma companies are likely to put up aggressive resistance to the measure, introduced earlier this month.
Here are the 40 upstarts and veterans who are transforming the healthcare industry.
Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.
Croom Lawrence and Kent Groves of Merkle Health explain being human.
Remedy Health Media's Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.
Dawn Hastings, associate creative director, Dudnyk, says using patients in campaigns for orphan drugs makes a brand's audience feel obligated to act.
At Work With
Rbb Communications' EVP of global and emerging markets, healthcare Srikant Ramaswami discusses how he keeps sane with his busy schedule and what inspires him.
Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised ...